The total return over the past 12 months is -76.74% vs. +16.94% for the S&P 500. So far it's up -67.44% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (76.75%) | (57.00%) | (63.83%) | (55.17%) | (49.65%) | (39.84%) |
| Total Return CAGR | (76.74%) | (56.99%) | (63.83%) | (55.17%) | (49.65%) | (39.84%) |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Imunon, Inc. (IMNN)
| Year | Start price | End price | IMNN Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $3.81 | $1.24 | (67.44%) | +14.51% | (81.95%) |
| 2025 | $14.25 | $3.81 | (73.27%) | +17.72% | (90.99%) |
| 2024 | $10.20 | $14.25 | +39.71% | +24.89% | +14.82% |
| 2023 | $20.25 | $10.20 | (49.63%) | +26.19% | (75.82%) |
| 2022 | $121.50 | $20.25 | (83.33%) | (18.17%) | (65.16%) |
| 2021 | $159.75 | $121.50 | (23.94%) | +28.74% | (52.68%) |
| 2020 | $384.75 | $159.75 | (58.48%) | +18.37% | (76.85%) |
| 2019 | $317.25 | $384.75 | +21.28% | +31.22% | (9.94%) |
| 2018 | $603.00 | $317.25 | (47.39%) | (4.56%) | (42.83%) |
| 2017 | $945.00 | $603.00 | (36.19%) | +21.70% | (57.89%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
